
As of FY25, Sanofi India had total assets of ₹4,401 crore and borrowings of ₹812 crore, against shareholders' equity of ₹3,167 crore — a debt-to-equity ratio of 0.35.
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 3,047 |
| Borrowings | 812 |
| Other liabilities | 542 |
| Total liabilities | 4,401 |
| Fixed assets | 2,370 |
| Capital work in progress | 45 |
| Investments | 1,016 |
| Other assets | 1,016 |
| Total assets | 4,401 |
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Sanofi India reported borrowings of ₹812 crore as of FY25.
Based on the FY25 balance sheet, Sanofi India's debt-to-equity ratio is 0.35 — borrowings of ₹812 crore against equity capital and reserves of ₹3,167 crore.
Sanofi India's total assets were ₹4,401 crore as of FY25, including fixed assets of ₹2,370 crore and investments of ₹1,016 crore.
The book value per share of Sanofi India is ₹1,031.54, based on the latest reported balance sheet.
Track SANOFI live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.